Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 13.39
+0.63 (4.94%)
At close: Sep 4, 2026
Cian Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 335 | 125 | 86 | 517 | 700 | 476 | |
Market Cap Growth | 285.94% | 45.24% | -83.31% | -26.18% | 46.98% | 81.19% |
Enterprise Value | 609 | 568 | 631 | 1,089 | 1,315 | 1,098 |
Last Close Price | 13.39 | 5.01 | 3.45 | 20.67 | 28.00 | 19.05 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 60.88 | 34.49 | - |
PS Ratio | 1.14 | 0.43 | 0.28 | 0.84 | 1.02 | 0.61 |
PB Ratio | 3.92 | 1.47 | 0.27 | 0.89 | 1.22 | 0.86 |
P/TBV Ratio | 3.92 | 1.47 | 0.27 | 0.89 | 1.22 | 0.86 |
P/FCF Ratio | - | - | 0.42 | 4.79 | 19.91 | - |
P/OCF Ratio | - | - | 0.42 | 4.39 | 14.46 | 5.55 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.07 | 1.93 | 2.05 | 1.76 | 1.92 | 1.41 |
EV/EBITDA Ratio | - | - | - | 9.67 | 10.06 | 24.08 |
EV/EBIT Ratio | - | - | - | 18.78 | 17.20 | 383.92 |
EV/FCF Ratio | - | - | 3.10 | 10.10 | 37.40 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 3.36 | 3.36 | 1.70 | 0.96 | 1.06 | 1.14 |
Debt / EBITDA Ratio | - | - | - | 4.94 | 4.65 | 13.82 |
Debt / FCF Ratio | - | - | 2.70 | 5.16 | 17.30 | - |
Net Debt / Equity Ratio | 3.22 | 3.22 | 1.15 | 0.93 | 1.03 | 1.11 |
Net Debt / EBITDA Ratio | -4.77 | -4.77 | -5.70 | 4.84 | 4.55 | 13.53 |
Net Debt / FCF Ratio | -11.98 | -11.98 | 1.83 | 5.05 | 16.92 | -7.06 |
Asset Turnover | 0.27 | 0.27 | 0.20 | 0.39 | 0.42 | 0.48 |
Inventory Turnover | 1.45 | 1.45 | 0.69 | 0.81 | 0.90 | 1.39 |
Quick Ratio | 0.48 | 0.48 | 0.35 | 0.40 | 0.50 | 0.50 |
Current Ratio | 0.79 | 0.79 | 0.62 | 1.09 | 1.14 | 1.14 |
Return on Equity (ROE) | -113.92% | -113.92% | -57.29% | 1.47% | 3.59% | -9.73% |
Return on Assets (ROA) | -5.55% | -5.55% | -4.30% | 2.25% | 2.93% | 0.11% |
Return on Invested Capital (ROIC) | -26.86% | -18.32% | -11.97% | 5.05% | 6.53% | 0.24% |
Return on Capital Employed (ROCE) | -29.80% | -29.80% | -26.30% | 6.10% | 8.00% | 0.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -69.58% | -185.97% | -301.24% | 1.64% | 2.90% | -11.62% |
FCF Yield | -6.85% | -18.30% | 235.94% | 20.88% | 5.02% | -18.36% |
Buyback Yield / Dilution | 0.04% | 0.01% | - | -0.00% | - | 5.85% |